Biographies Speakers

Arnold G. Vulto obtained his pharmacy degree from Groningen University (The Netherlands) in 1981, with undergraduate studies in Cambridge (UK). He was trained as a pharmacologist at the Rudolf Magnus Institute at the University of Utrecht and at the Karolinska Institute (Stockholm, Sweden). He specialised in hospital pharmacy at the University Hospital Maastricht and obtained his PhD from Utrecht University. In 1988 he was appointed Head of the Hospital Pharmacy of the Veterinary Faculty, University of Utrecht and in 1995 as Deputy Head / Research director of the Hospital Pharmacy of the Erasmus University Medical Center in Rotterdam (until 2017). In 2004 he was appointed Professor of Hospital Pharmacy & Practical Therapeutics at the Erasmus University Rotterdam. Professor Vulto is the (co)author of more than 140 international peer-reviewed papers and has been supervising more than 20 PhD projects. He was member of the Board of the European Association of Hospital Pharmacists (EAHP) and was Chairman of its Scientific Committee. He was a member of the Steering Committee and chair of the Program Committee of the First Global Conference on the Future of Hospital Pharmacy (Basel). In 2008 he was one of the founders of the Generics & Biosimilars Initiative (GaBI), followed by the foundation of the Dutch Initiatiefgroep Biosimilars in 2013. In 2016 he was one of the founders of the MABEL Research Fund at Leuven University, aimed at investigating developments in the biologics market after loss of market exclusivity. In 2010 he was elected as Fellow of the American College of Clinical Pharmacology. He received different awards: “Visionary guidance and leadership” in hospital pharmacy (EAHP) and the Jan Glerum Lifetime Achievement Award for his contribution to the training of hospital pharmacists. Professor Vulto was for almost 10 years Editor in Chief of the European Journal of Hospital Pharmacy Practice.